Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703818 · ClinicalTrials.gov registry record · NA
SCS for the Treatment Of Chronic Pain of the Upper Extremities
A NA study of Upper Extremity Pain, sponsored by Nevro.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT02703818: Completed NA study of Upper Extremity Pain, sponsored by Nevro.
NCT02703818 is a NA study of Upper Extremity Pain that has completed, run by Nevro. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02703818, a NA study of Upper Extremity Pain, has completed, sponsored by Nevro.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.
Conditions Studied
Interventions
- DEVICE Senza
Study Locations (1)
California
- NEVRO Corp - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02703818 record still lists
NCT02703818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Upper Extremity Pain appearing as the primary indexed condition, and to 1 intervention - of which Senza is the first listed.
NCT02703818 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02703818 about?
NCT02703818 is a clinical study titled "SCS for the Treatment Of Chronic Pain of the Upper Extremities". This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.
What is the current status of trial NCT02703818?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-02. Estimated completion is 2018-05.
What conditions does trial NCT02703818 study?
This clinical trial studies the following conditions: Upper Extremity Pain.
What interventions are being tested in trial NCT02703818?
The interventions under investigation include: Senza (DEVICE).
Who is sponsoring clinical trial NCT02703818?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703818 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Extremity Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02703818's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia